Latest News

MEI Pharma Announces Expansion of Phase 1b Study Evaluating Zandelisib and Clinical Pipeline Update
MEI Pharma Reports First Quarter Fiscal Year 2021 Results and Operational Highlights
MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences
Kyowa Kirin and MEI Pharma Announce First Patient Dosed in Japanese Pivotal Phase 2 Study of Zandelisib in Patients with Indolent B-cell non-Hodgkin's Lymphoma